Related Experiment Videos
Pulmonary lymphangiectasia revisited
S Bouchard1, M Di Lorenzo, S Youssef
1Department of Surgery, University of Montreal, Sainte-Justine Hospital, Quebec, Canada.
Journal of Pediatric Surgery
|May 17, 2000
Summary
Pulmonary lymphangiectasia (PL) is a rare condition. Survival is possible if diagnosed past the neonatal period, with symptom improvement expected in long-term survivors.
Area of Science:
- Pediatric Pulmonology
- Medical Genetics
Background:
- Pulmonary lymphangiectasia (PL) is a rare congenital disorder characterized by abnormal lymphatic development in the lungs.
- Limited data exists on the long-term outcomes and survival of individuals with PL beyond the neonatal period.
Purpose of the Study:
- To investigate the clinical course and outcomes of patients diagnosed with pulmonary lymphangiectasia (PL).
- To provide insights into the long-term prognosis and management of PL survivors.
Main Methods:
- Retrospective review of histologically confirmed cases of pulmonary lymphangiectasia (PL) from 1965 onwards.
- Inclusion of both fetal and pediatric cases, including long-term survivors.
Main Results:
- Eleven pediatric cases and 8 fetal cases of PL were identified.
- Of the 11 children, 5 survived beyond the neonatal period, with diminishing symptomatology and hospital admissions over time.
- Common symptoms included respiratory distress, recurrent pneumonia, and cough; associated conditions like Noonan syndrome and cardiac malformations were noted.
Conclusions:
- This study represents the first long-term investigation of primary pulmonary lymphangiectasia (PL).
- While often fatal neonatally, survival is achievable with diagnosis beyond the neonatal period, and improvement in condition is anticipated.
- Findings can aid in parental counseling and understanding the disease trajectory.